New study adds to the evidence base for S3 celecoxib

A new systematic review and meta-analysis published in Drugs addresses an evidence gap for S3 celecoxib, helping pharmacists to manage acute pain.1 Pharmacists are ideally placed to support the short-term management of acute pain, with access to a range of treatment options from over- and behind-the-counter.2 Since February 2024, pharmacists have been able to recommend